Dong Quai (Angelica sinensis).

Dong quai's coumarin constituents and ginkgo's terpene lactones both dampen platelet aggregation, so together they can add up and leave normal clotting slower to engage. Pairing them warrants extra care for anyone whose blood already clots slowly.

White willow bark supplies salicylates that keep platelets from sticking together, and dong quai's coumarin compounds nudge the same process, so the two overlap in how they affect normal blood clotting. Their effects add together rather than complement.

The EPA and DHA in fish oil shift platelet signaling toward less aggregation, and dong quai's coumarins push in the same direction, so the pair can compound how loosely platelets bind. Worth noting for people already watching their clotting.

Garlic's organosulfur compounds reduce platelet stickiness, a mechanism that runs parallel to dong quai's mild coumarin-driven antiplatelet action. Combined, they can add together in how they influence normal clot formation.

Dong quai and astragalus are the two herbs of the classical dang gui bu xue tang pairing, used together for centuries at a fixed ratio. The combination is the oldest established formulation use of dong quai.

Black cohosh acts on serotonergic and central thermoregulatory signalling rather than binding oestrogen receptors, a different lever from dong quai's ligustilide and ferulic acid constituents. Midlife hormonal formulas have combined them for decades.

Chasteberry works through dopaminergic modulation of prolactin release, upstream of the cycle-related tissue effects dong quai is used for. Women's cycle blends carry the pair on that split of mechanism.

Licorice is the standard harmoniser alongside dong quai in classical formulas, and its glycyrrhizin also alters the metabolism and absorption of co-taken constituents. The pairing is both traditional and pharmacologically active.

Evening primrose supplies gamma-linolenic acid for series-one prostaglandin production, a fatty acid route dong quai does not touch. Women's formulas combine the botanical and the oil.

Curcumin reduces thromboxane formation and platelet activation, and dong quai coumarins act on normal clotting from a separate direction. Together the effect on platelet aggregation adds up.

Gingerols inhibit thromboxane synthase, lengthening normal platelet aggregation, which is the same direction dong quai's coumarins push. Stacked botanicals of this kind compound the effect.

At high intakes tocopherol reduces platelet adhesion and interacts with vitamin K dependent clotting factors. Combined with dong quai's coumarin constituents the effect on normal clotting is additive.

Dong quai contains furanocoumarins and St John's wort contains hypericin, and both raise skin sensitivity to sunlight. Taking them together adds two photosensitising constituents at once.

Angelica sinensis carries coumarin-type constituents and is listed in clinical reference sources among botanicals to account for when clotting is a consideration. Nattokinase has its own fibrinolytic activity. The direction of the combination is additive, which is what makes it worth flagging rather than recommending.

Bromelain appears in reference sources among the enzymes associated with reduced platelet aggregation, alongside the fish oil and ginkgo already stored as partners here. Stacking several such ingredients compounds the same direction of effect. This is a caution to disclose rather than a pairing to build around.

Grape seed proanthocyanidins are among the polyphenols associated with reduced platelet aggregation in laboratory and small human work. Adding them to a formula that already contains dong quai, ginkgo and fish oil stacks the same direction repeatedly. Mechanistic and observational grounding, not a combination trial.

Pine bark extract carries the same class of proanthocyanidins as grape seed and is associated with platelet effects in small human studies. Combined with dong quai the effects run in the same direction. The clinically relevant point is disclosure before any procedure, not a benefit claim.

Dong quai is a component of traditional multi-herb formulas studied alongside iron for low iron status, and a 2024 systematic review examined that literature while noting limitations in study quality. Separately, polyphenols in root extracts bind non-heme iron in the gut and reduce its uptake. The two points pull in different directions, which is why timing of an iron dose relative to a herbal decoction matters.

Red clover carries isoflavones that bind oestrogen receptors with a preference for the beta subtype, and it is commonly formulated with dong quai and black cohosh for midlife support. The mechanisms differ, since dong quai's oestrogen receptor activity is not well characterised. Anyone with a hormone-sensitive history should raise the pairing with their clinician.

Ascorbic acid reduces ferric iron to the ferrous form and keeps it soluble in the intestinal lumen, which raises non-heme iron uptake and partly offsets polyphenol binding. Dong quai formulas used for iron support are traditionally taken with foods rich in ascorbate. The effect on iron absorption is established; the wider formula claim is not.

Quercetin appears among the flavonoids associated with reduced platelet aggregation in laboratory work, which stacks with the direction already contributed by dong quai and the fish oil stored here. It also chelates non-heme iron. Both points are about combination behaviour rather than a benefit of the pair.